home.aspx
 
EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...

Artemis Hospitals

SHARESHARESHARE
Artemis Hospitals is a healthcare venture, launched in 2007, by the promoters of the Apollo Tyres Group. Artemis is the first hospital in Gurgaon to be accredited by JCI and NABH. Designed as one of the most advanced in India, Artemis provides an in-depth expertise in the sphere of advanced medical & surgical interventions, comprehensive mix of inpatient and outpatient services. Artemis aims to provide excellent medical care in a compassionate environment and a practice dedicated to pioneering research, empowering the health care professionals and the diverse communities we serve. The clinical procedures followed in the hospital are technologically advanced and supervised by distinguished doctors of international repute. Our endeavor to deliver standard-setting medical care is lead by the needs of the patient; our exceptional medical facilities and unmatched responsiveness has made us one of the most revered hospitals in the country.
SHARESHARESHARE

RELATED NEWS


Recently, multinational retail corporation, Walmart and retail pharmacy, and health care firm CVS have disclosed that they have moved past their pricing disagreement of filling prescriptions. Earlier, the dispute was about the involvement of Walmart in CVS Caremark’s and Managed Medicaid pharmacy networks. The financial details of the multi-year agreement weren’t revealed. On January 14, 2019, CVS had revealed that Walmart was anticipated to leave the drugstore networks. This would h...

READ MORE

To help ensure more affordable and timely access to patients most in need, Sanofi and Regeneron Pharmaceuticals, will offer US payers that agree to reduce burdensome access barriers for high-risk patients a further reduced net price for Praluent (alirocumab) injection in alignment with a new value assessment for high-risk patients from the US Institute for Clinical and Economic Review (ICER).  The companies will take a precision medicine approach, to address the burden of cardiovascular dis...
PHARMABIZ.COM
READ MORE

The Food and Drug Administration approved Endomagnetics Inc.’s magnetic tracer injection and detection system for guiding lymph node biopsies in patients with breast cancer undergoing the mastectomy. In the procedure, the clinician injects a solution of dextran-coated iron oxide magnetic nanoparticles (Magtrace) in the vicinity of a tumor or the areola, as is done typically with dye or radioactive tracers. The Magtrace then clears along lymphatic vessels and labels the sentinel and drainin...

READ MORE

Roche and Spark Therapeutics road to a 4.3 billion dollars merger has been a rocky one, with various delays pushing the long-gestating agreement back four times. Now, in order to get all its regulatory ducks in a row, Roche is moving its own deal-close deadline back as well. Roche moved its Spark closing deadline from Jan. 31, 2020 to April 30, 2020, according to a Monday regulatory filing. The move is a precautionary one, meant to give the deal partners time to clear any hurdles that may come u...

READ MORE

It feels sometimes as if Bristol-Myers Squibb’s checkpoint inhibitor Opdivo (nivolumab) is a miraculous cancer drug, given the number of indications it has been approved for. And in many ways it is. However, it apparently can’t do everything, and the company announced today that the drug failed to meet its primary endpoint in patients with newly diagnosed O6-methylguanine-DNA methyltransferase (MGMT)-unmethylated glioblastoma multiforme (GBM), a type of brain cancer. The drug was bei...

READ MORE

The world's biggest pharmaceutical companies are revealing prices of their prescription drugs on websites for the first time in a bid to stave off pressure from the Trump administration to make even more public disclosures. The move by companies ranging from pharma giant Pfizer to biotechnology pioneer Amgen comes almost a year after President Donald Trump suggested in a blueprint for lowering medical costs that the government might require drugmakers to put list prices in their TV advertise...

READ MORE

EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...